Dow Jones

38,686.32

1.51%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

LMDX

LumiraDx (LMDX)

LumiraDx Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LMDX

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
05/01/2024	16:45	GlobeNewswire Inc.	LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th	NASDAQ:LMDX	LumiraDx Ltd
29/12/2023	16:07	Dow Jones News	LumiraDx Agrees to Sell Point-of-Care Tech Platform to Roche	NASDAQ:LMDX	LumiraDx Ltd
29/12/2023	15:15	GlobeNewswire Inc.	LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche	NASDAQ:LMDX	LumiraDx Ltd
27/10/2023	15:45	GlobeNewswire Inc.	LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal	NASDAQ:LMDX	LumiraDx Ltd
20/10/2023	17:34	GlobeNewswire Inc.	LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub	NASDAQ:LMDX	LumiraDx Ltd
24/08/2023	06:45	GlobeNewswire Inc.	LumiraDx Reports Second Quarter 2023 Results	NASDAQ:LMDX	LumiraDx Ltd
16/08/2023	15:30	GlobeNewswire Inc.	LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24	NASDAQ:LMDX	LumiraDx Ltd
31/07/2023	05:00	GlobeNewswire Inc.	LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests	NASDAQ:LMDX	LumiraDx Ltd
30/06/2023	14:26	Dow Jones News	LumiraDx Submits Dual FDA Medical Device Application for Covid-19 Test	NASDAQ:LMDX	LumiraDx Ltd
30/06/2023	13:30	GlobeNewswire Inc.	LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test	NASDAQ:LMDX	LumiraDx Ltd
20/06/2023	15:15	GlobeNewswire Inc.	LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests	NASDAQ:LMDX	LumiraDx Ltd
16/05/2023	06:45	GlobeNewswire Inc.	LumiraDx Reports First Quarter 2023 Results	NASDAQ:LMDX	LumiraDx Ltd
09/05/2023	15:15	GlobeNewswire Inc.	LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16	NASDAQ:LMDX	LumiraDx Ltd
24/04/2023	15:21	GlobeNewswire Inc.	LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	NASDAQ:LMDX	LumiraDx Ltd
06/04/2023	08:20	GlobeNewswire Inc.	LumiraDx Announces Strategic Refocus and Cost Restructuring Program	NASDAQ:LMDX	LumiraDx Ltd
21/03/2023	06:26	GlobeNewswire Inc.	LumiraDx Reports Fourth Quarter and Full Year 2022 Results	NASDAQ:LMDX	LumiraDx Ltd
14/03/2023	07:03	GlobeNewswire Inc.	LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21	NASDAQ:LMDX	LumiraDx Ltd
03/03/2023	08:00	GlobeNewswire Inc.	LumiraDx to Present at Raymond James Institutional Investors Conference	NASDAQ:LMDX	LumiraDx Ltd
20/02/2023	10:00	GlobeNewswire Inc.	LumiraDx Regains Compliance with Nasdaq Continued Listing Requirements	NASDAQ:LMDX	LumiraDx Ltd
06/02/2023	07:59	Dow Jones News	LumiraDx Gets FDA Emergency Authorization for Dual Flu-COVID Test	NASDAQ:LMDX	LumiraDx Ltd
06/02/2023	07:00	GlobeNewswire Inc.	LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular Assay	NASDAQ:LMDX	LumiraDx Ltd
31/01/2023	15:30	GlobeNewswire Inc.	LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Heart Health Checks in UK	NASDAQ:LMDX	LumiraDx Ltd
31/01/2023	15:15	GlobeNewswire Inc.	LumiraDx Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency	NASDAQ:LMDX	LumiraDx Ltd
14/12/2022	02:19	GlobeNewswire Inc.	LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis Test	NASDAQ:LMDX	LumiraDx Ltd
08/12/2022	02:01	GlobeNewswire Inc.	Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to Address Healthcare Bandwidth Pressures and Anticipates Future Growth of POCT in Community Testing Centers	NASDAQ:LMDX	LumiraDx Ltd
14/11/2022	08:44	PR Newswire (US)	LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test	NASDAQ:LMDX	LumiraDx Ltd
13/11/2022	22:05	TipRanks	LumiraDx (LMDX) Gets a Buy from BTIG	NASDAQ:LMDX	LumiraDx Ltd
11/11/2022	06:35	TipRanks	Raymond James Remains a Buy on LumiraDx (LMDX)	NASDAQ:LMDX	LumiraDx Ltd
09/11/2022	06:00	GlobeNewswire Inc.	LumiraDx Reports Third Quarter 2022 Results	NASDAQ:LMDX	LumiraDx Ltd
02/11/2022	06:23	GlobeNewswire Inc.	LumiraDx to Announce Third Quarter Financial Results and Host Quarterly Conference Call on November 9	NASDAQ:LMDX	LumiraDx Ltd